Nanbin Liu

Integrative pan-cancer profiling identifies BRIX1 as a candidate prognostic biomarker and potential therapeutic target in liver hepatocellular carcinoma

BRIX1 belongs to the Brix domain-containing protein family and participates in ribosomal assembly and in cell growth regulation. Nevertheless, a systematic pan-cancer assessment of BRIX1 expression and its clinical implications in liver hepatocellular carcinoma (LIHC) remains lac...